Evidence map›Paper›PMID 22304380›Full record

ArticleBiochemistry2012

Using a low denaturant model to explore the conformational features of translocation-active SecA.

Jenny L Maki, Beena Krishnan, Lila M Gierasch

Abstract read
In one paragraph

Article in Biochemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Stabilization of SecA ATPase by the primary cytoplasmic salt of Escherichia coli.Protein science : a publication of the Protein Society · 2019
    Article
  2. Article
  3. Article
  4. Stoichiometry of SecYEG in the active translocase of Escherichia coli varies with precursor species.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jenny L MakiProgram in Molecular and Cellular Biology, University of Massachusetts Amherst, Amherst, Massachusetts 01003, United States.
Beena Krishnan
Lila M Gierasch

Funding

CHEMISTRY-BIOLOGY INTERFACE PREDOCTORAL TRAINING GRANTST32GM008515 · NIGMS · UNIVERSITY OF MASSACHUSETTS AMHERST · PI THOMPSON, LYNMARIE K. · 1995 to 2020
$4.3M
NIH DIRECTOR'S PIONEER AWARDDP1OD000945 · OD · UNIVERSITY OF MASSACHUSETTS AMHERST · PI GIERASCH, LILA M · 2006 to 2010
$3.9M
TARGETING SEQUENCES;CONFORMATIONS &INTERACTIONSR01GM034962 · NIGMS · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI GIERASCH, LILA M · 1985 to 2006
$1.4M
NIGMS NIH HHS GM034962NIGMS NIH HHS R01 GM034962NIGMS NIH HHS T32 GM008515NIH HHS DP1 OD000945
6 · The paper itself

Abstract

The SecA molecular nanomachine in bacteria uses energy from ATP hydrolysis to drive post-translational secretion of preproteins through the SecYEG translocon. Cytosolic SecA exists in a dimeric, "closed" state with relatively low ATPase activity. After binding to the translocon, SecA undergoes major conformational rearrangement, leading to a state that is structurally more "open", has elevated ATPase activity, and is active in translocation. The structural details underlying this conformational change in SecA remain incompletely defined. Most SecA crystal structures report on the cytosolic form; only one structure sheds light on a form of SecA that has engaged the translocon. We have used mild destabilization of SecA to trigger conformational changes that mimic those in translocation-active SecA and thus study its structural changes in a simplified, soluble system. Results from circular dichroism, tryptophan fluorescence, and limited proteolysis demonstrate that the SecA conformational reorganization involves disruption of several domain-domain interfaces, partial unfolding of the second nucleotide binding fold (NBF) II, partial dissociation of the helical scaffold domain (HSD) from NBF I and II, and restructuring of the 30 kDa C-terminal region. These changes account for the observed high translocation SecA ATPase activity because they lead to the release of an inhibitory C-terminal segment (called intramolecular regulator of ATPase 1, or IRA1) and of constraints on NBF II (or IRA2) that allow it to stimulate ATPase activity. The observed conformational changes thus position SecA for productive interaction with the SecYEG translocon and for transfer of segments of its passenger protein across the translocon.

Indexed as

Adenosine TriphosphatasesAdenosine TriphosphateBacillus subtilisBacterial ProteinsBenzophenonesCross-Linking ReagentsCytosolEscherichia coliEscherichia coli ProteinsHydrolysisMaleimidesMembrane ProteinsMembrane Transport ProteinsProtein ConformationProtein DenaturationProtein Sorting SignalsAdenosine TriphosphatasesAdenosine TriphosphateBacterial Proteinsbenzophenone-4-maleimideBenzophenonesCross-Linking ReagentsEscherichia coli ProteinsMaleimidesMembrane ProteinsMembrane Transport ProteinsProtein Sorting SignalsSecA ProteinsSecE protein, E coliSecG protein, E coliSEC Translocation ChannelsSecY protein, E coliTryptophan

Identifiers

PMID22304380
PMCPMC3290997

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.